Health Catalyst(DE:2YP)
€1.35+0.03 (+2.35%)
DE:2YP
Health Catalyst financials statements
€1.35
At close:+0.03 (+2.35%)
Health Catalyst (2YP) Ratios
0 Followers
Health Catalyst Ratios
DE:2YP's free cash flow for Q3 2026 was $7.38M. For the 2026 fiscal year, DE:2YP's free cash flow was increased by $9.25M and operating cash flow was $-1.88M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.89 | 1.43 | 4.42 | 5.18 | 5.46 |
| Quick Ratio | 1.89 | 1.43 | 4.42 | 5.18 | 5.46 |
| Cash Ratio | 0.57 | 0.77 | 1.19 | 1.41 | 2.08 |
| Solvency Ratio | -0.50 | -0.06 | -0.23 | -0.26 | -0.36 |
| Operating Cash Flow Ratio | 0.01 | 0.04 | -0.37 | -0.43 | -0.25 |
| Short-Term Operating Cash Flow Coverage | 0.45 | 0.06 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -87.56M | $ -28.07M | $ 58.50M | $ 100.52M | $ 198.39M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.34 | 0.47 | 0.35 | 0.33 | 0.25 |
| Debt-to-Equity Ratio | 0.70 | 1.10 | 0.68 | 0.58 | 0.39 |
| Debt-to-Capital Ratio | 0.41 | 0.52 | 0.40 | 0.37 | 0.28 |
| Long-Term Debt-to-Capital Ratio | 0.38 | 0.29 | 0.38 | 0.35 | 0.26 |
| Financial Leverage Ratio | 2.05 | 2.35 | 1.91 | 1.77 | 1.59 |
| Debt Service Coverage Ratio | -6.16 | -0.04 | -9.42 | -10.86 | -5.47 |
| Interest Coverage Ratio | -2.20 | -4.09 | -17.41 | -19.34 | -8.30 |
| Debt to Market Cap | 0.92 | 0.90 | 0.44 | 0.40 | 0.10 |
| Interest Debt Per Share | 2.68 | 6.97 | 4.54 | 4.75 | 4.67 |
| Net Debt to EBITDA | -1.09 | -14.33 | -2.09 | -1.59 | -0.11 |
| Profitability Margins | |||||
| Gross Profit Margin | 33.47% | 45.92% | 44.55% | 48.21% | 48.60% |
| EBIT Margin | -51.70% | -16.99% | -37.34% | -48.67% | -59.02% |
| EBITDA Margin | -35.47% | -3.47% | -23.07% | -30.02% | -42.03% |
| Operating Profit Margin | -11.60% | -22.77% | -42.88% | -50.68% | -59.38% |
| Pretax Profit Margin | -56.97% | -22.56% | -39.80% | -51.29% | -66.18% |
| Net Profit Margin | -57.20% | -22.67% | -39.92% | -49.74% | -63.33% |
| Continuous Operations Profit Margin | -57.20% | -22.67% | -39.92% | -49.74% | -63.33% |
| Net Income Per EBT | 100.40% | 100.48% | 100.30% | 96.98% | 95.69% |
| EBT Per EBIT | 490.96% | 99.09% | 92.82% | 101.20% | 111.46% |
| Return on Assets (ROA) | -35.41% | -8.09% | -16.83% | -18.26% | -18.41% |
| Return on Equity (ROE) | -72.41% | -19.03% | -32.20% | -32.33% | -29.35% |
| Return on Capital Employed (ROCE) | -8.74% | -13.09% | -20.71% | -20.90% | -19.44% |
| Return on Invested Capital (ROIC) | -8.63% | -9.09% | -20.60% | -20.17% | -18.51% |
| Return on Tangible Assets | -82.44% | -13.55% | -26.99% | -28.98% | -27.49% |
| Earnings Yield | -106.54% | -16.33% | -22.61% | -24.06% | -8.14% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.26 | 5.36 | 4.91 | 5.76 | 4.96 |
| Payables Turnover | 22.11 | 14.50 | 24.71 | 32.33 | 26.50 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 7.69 | 7.40 | 7.47 | 6.49 | 5.44 |
| Asset Turnover | 0.62 | 0.36 | 0.42 | 0.37 | 0.29 |
| Working Capital Turnover Ratio | 2.83 | 1.38 | 0.91 | 0.73 | 0.74 |
| Cash Conversion Cycle | 52.85 | 42.91 | 59.59 | 52.10 | 59.85 |
| Days of Sales Outstanding | 69.36 | 68.08 | 74.36 | 63.38 | 73.63 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 16.51 | 25.17 | 14.77 | 11.29 | 13.77 |
| Operating Cycle | 69.36 | 68.08 | 74.36 | 63.38 | 73.63 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.01 | 0.24 | -0.59 | -0.66 | -0.49 |
| Free Cash Flow Per Share | -0.00 | -0.03 | -0.84 | -0.98 | -0.88 |
| Dividend Paid and CapEx Coverage Ratio | 0.76 | 0.89 | -2.31 | -2.03 | -1.25 |
| Capital Expenditure Coverage Ratio | 0.76 | 0.89 | -2.31 | -2.03 | -1.25 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.04 | -0.13 | -0.14 | -0.11 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.05 | -0.11 | -0.13 | -0.10 |
| Free Cash Flow Yield | -0.14% | -0.43% | -9.07% | -9.23% | -2.21% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.94 | -6.15 | -4.42 | -4.16 | -12.28 |
| Price-to-Sales (P/S) Ratio | 0.54 | 1.39 | 1.77 | 2.07 | 7.78 |
| Price-to-Book (P/B) Ratio | 0.68 | 1.17 | 1.42 | 1.34 | 3.60 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -704.86 | -231.38 | -11.02 | -10.84 | -45.25 |
| Price-to-Operating Cash Flow Ratio | 228.52 | 29.23 | -15.79 | -16.19 | -81.38 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.14 | 0.24 | 0.20 | -1.12 |
| Enterprise Value Multiple | -2.61 | -54.27 | -9.74 | -8.48 | -18.62 |
| Enterprise Value | 287.48M | 578.13M | 665.22M | 702.72M | 1.89B |
| EV to EBITDA | -2.61 | -54.27 | -9.74 | -8.48 | -18.62 |
| EV to Sales | 0.92 | 1.89 | 2.25 | 2.54 | 7.83 |
| EV to Free Cash Flow | -1212.98 | -314.37 | -14.04 | -13.34 | -45.52 |
| EV to Operating Cash Flow | 393.26 | 39.71 | -20.11 | -19.92 | -81.87 |
| Tangible Book Value Per Share | -0.59 | 0.32 | 1.82 | 2.73 | 5.21 |
| Shareholders’ Equity Per Share | 3.52 | 6.07 | 6.50 | 7.91 | 10.99 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | 0.03 | 0.04 |
| Revenue Per Share | 4.45 | 5.09 | 5.25 | 5.14 | 5.09 |
| Net Income Per Share | -2.55 | -1.15 | -2.09 | -2.56 | -3.23 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.97 | 0.96 |
| Interest Burden | 1.10 | 1.33 | 1.07 | 1.05 | 1.12 |
| Research & Development to Revenue | 0.16 | 0.19 | 0.25 | 0.27 | 0.26 |
| SG&A to Revenue | 0.33 | 0.36 | 0.26 | 0.22 | 0.36 |
| Stock-Based Compensation to Revenue | 0.09 | 0.13 | 0.19 | 0.26 | 0.27 |
| Income Quality | -0.00 | -0.21 | 0.28 | 0.26 | 0.15 |
Currency in USD
